Milestone Pharmaceuticals (MIST) Operating Income (2018 - 2022)
Milestone Pharmaceuticals (MIST) posted Operating Income of -$15.0 million for Q3 2022, up 10.57% on a QoQ basis from -$16.8 million in Q2 2022, and down 5.3% year-over-year from -$15.9 million in Q3 2021.
Milestone Pharmaceuticals (MIST) Operating Income (2018 - 2022) Analysis & Trends
Milestone Pharmaceuticals' Operating Income history runs 5 years deep, the most recent figure standing at -$15.0 million for Q3 2022.
- Quarterly Operating Income fell 5.3% year-over-year to -$15.0 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$63.0 million (down 80.51% YoY) and the FY2021 annual result came in at -$43.1 million, up 15.06% from the prior year.
- Operating Income was -$15.0 million for Q3 2022 at Milestone Pharmaceuticals, up from -$16.8 million in the prior quarter.
- Across five years, Operating Income topped out at $712000.0 in Q2 2021 and bottomed at -$18.9 million in Q4 2019.
- A 5-year average of -$11.5 million and a median of -$12.8 million in 2020 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2021 — Operating Income jumped 105.43% — and 2022, when it slumped 2460.39%.
- Milestone Pharmaceuticals' Operating Income stood at -$10.1 million in 2018, then slumped by 86.92% to -$18.9 million in 2019, then surged by 53.62% to -$8.8 million in 2020, then tumbled by 93.08% to -$16.9 million in 2021, then climbed by 11.16% to -$15.0 million in 2022.
- Business Quant data shows MIST's Operating Income at -$15.0 million in Q3 2022, -$16.8 million in Q2 2022, and -$16.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -15.03 Mn |
| Jun 30, 2022 | -16.81 Mn |
| Dec 31, 2021 | -16.92 Mn |
| Sep 30, 2021 | -14.27 Mn |
| Jun 30, 2021 | 712,000.00 |
| Mar 31, 2021 | -12.59 Mn |
| Dec 31, 2020 | -8.76 Mn |
| Sep 30, 2020 | -12.09 Mn |
| Jun 30, 2020 | -13.11 Mn |
| Mar 31, 2020 | -16.76 Mn |
| Dec 31, 2019 | -18.89 Mn |
| Sep 30, 2019 | -13.73 Mn |
| Jun 30, 2019 | -14.33 Mn |
| Mar 31, 2019 | -10.93 Mn |
| Dec 31, 2018 | -10.11 Mn |
| Sep 30, 2018 | -5.79 Mn |
| Jun 30, 2018 | -3.68 Mn |
| Mar 31, 2018 | -4.26 Mn |